{
  "id": "6026d8bf1cb411341a0000ce",
  "type": "factoid",
  "question": "What is the mode of administration of Ubrogepant?",
  "ideal_answer": "Ubrogepant (MK-1602) is administered orally.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31537107",
    "http://www.ncbi.nlm.nih.gov/pubmed/31899602",
    "http://www.ncbi.nlm.nih.gov/pubmed/31758661",
    "http://www.ncbi.nlm.nih.gov/pubmed/29136283",
    "http://www.ncbi.nlm.nih.gov/pubmed/32020557"
  ],
  "snippets": [
    {
      "text": "Ubrogepant (MK-1602) is a novel, oral, calcitonin gene-related peptide receptor antagonist in clinical development with positive phase III outcomes for acute treatment of migraine. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31758661",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We applied this strategy for another late-stage clinical program: ubrogepant (MK-1602), a novel oral calcitonin gene-related peptide receptor antagonist for acute treatment of migraine.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29136283",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ubrogepant is a novel, oral calcitonin gene-related peptide (CGRP) receptor antagonist in development for the acute treatment of migraine.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31537107",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ubrogepant (Ubrelvy\u2122) is an orally administered, small molecule, highly-selective, calcitonin gene-related peptide (CGRP) antagonist that was developed by Allergan under license to Merck & Co. as an acute treatment for migraine.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32020557",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ubrogepant is a novel, oral calcitonin gene-related peptide (CGRP) receptor antagonist intended for the acute treatment of migraine attacks.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31899602",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "oral"
}